EUVIMEDEUVIMED entdecken
Crossref

Nesfatin‐1 alleviates hyperoxia‐induced bronchopulmonary dysplasia (BPD) via the nuclear factor‐κB (NF‐κB) p65 signaling pathway

Li Zhang, Zhang Zhuo, Lijuan Chen, Jiao Liu, Jiang Huang, Jian Deng, Wei Lu, Xian Jiang

Journal of Biochemical and Molecular Toxicology · 2024

DOI: 10.1002/jbt.23680 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2024. Verfasst von Li Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Luzhou People's Hospital, Luzhou, China. Hauptthemen laut MEDLINE: Bronchopulmonary Dysplasia, Hyperoxia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: The Second Batch of Planned Projects of Science and Technology Department of Sichuan Provincial, Luzhou Science and Technology Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bronchopulmonary dysplasia (BPD) is a chronic respiratory disease in newborns, which severely influences the health of infants and lacks effective clinical treatment strategies. The pathogenesis of BPD is correlated to enhanced inflammation and activated oxidative stress (OS). The application of antioxidants and anti‐inflammatory treatment could be hot spots for BPD treatment. Nesfatin‐1, a peptide with a suppressive property against inflammation, was tested herein for its potential therapeutic value in BPD. Neonatal SD rats were stimulated with hyperoxia, followed by being intraperitoneally administered with 20 μg/kg/day Nesfatin‐1 for 2 weeks. Decreased RAC value in lung tissues, increased wet weight/dry weight (W/D) pulmonary ratio and bronchoalveolar lavage fluid (BALF) proteins, elevated cytokine release in BALF, increased malondialdehyde (MDA) content, and declined superoxide dismutase (SOD) activity were observed in BPD rats, all of which were sharply mitigated by Nesfatin‐1. Rat epithelial type II cells (AECIIs) were handled with hyperoxia, and then cultured with 1 and 10 nM Nesfatin‐1. Reduced cell viability, elevated lactate dehydrogenase production, elevated cytokine secretion, elevated MDA content, and decreased SOD activity were observed in hyperoxia‐handled AECIIs, all of which were markedly alleviated by Nesfatin‐1. Furthermore, activated nuclear factor‐κB (NF‐κB) signaling observed in both BPD rats and hyperoxia‐handled AECIIs were notably repressed by Nesfatin‐1. Collectively, Nesfatin‐1 alleviated hyperoxia‐triggered BPD by repressing inflammation and OS via the NF‐κB signaling pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bronchopulmonary DysplasiaHyperoxiaAnimalsHumansInfant, NewbornRatsAnimals, NewbornCytokinesDisease Models, AnimalInflammationLungNF-kappa BRats, Sprague-DawleySignal TransductionSuperoxide DismutaseNucleobindins

Stichwörter der Autor:innen

NF‐κBNesfatin‐1bronchopulmonary dysplasiainflammationoxidative stress

Substanzen

CytokinesNF-kappa BSuperoxide DismutaseNucb2 protein, ratNucleobindins

Autor:innen und Institutionen

  • Department of Anesthesiology, Luzhou People's Hospital, Luzhou, China.
  • School of Pharmacy, Southwest Medical University, Luzhou, China.
  • Department of Pharmacy, Stomatology Hospital Affiliated to Southwest Medical University, Luzhou, China.
  • Department of Pharmacy, Affiliated Hospital of Southwest Medical University, Luzhou, China.
  • Department of Pharmacy, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China.
  • Department of Emergency, Luzhou People's Hospital, Luzhou, China.

Förderung

  • The Second Batch of Planned Projects of Science and Technology Department of Sichuan Provincial
  • Luzhou Science and Technology Bureau

Zitieren

APA

Zhang, L., Zhuo, Z., Chen, L., Liu, J., Huang, J., Deng, J., Lu, W., & Jiang, X. (2024). Nesfatin‐1 alleviates hyperoxia‐induced bronchopulmonary dysplasia (BPD) via the nuclear factor‐κB (NF‐κB) p65 signaling pathway. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.23680

Vancouver

Zhang L, Zhuo Z, Chen L, Liu J, Huang J, Deng J, et al. Nesfatin‐1 alleviates hyperoxia‐induced bronchopulmonary dysplasia (BPD) via the nuclear factor‐κB (NF‐κB) p65 signaling pathway. Journal of Biochemical and Molecular Toxicology. 2024. doi:10.1002/jbt.23680

BibTeX
@article{Zhang2024,
  author = {Zhang, Li and Zhuo, Zhang and Chen, Lijuan and Liu, Jiao and Huang, Jiang and Deng, Jian and Lu, Wei and Jiang, Xian},
  title = {Nesfatin‐1 alleviates hyperoxia‐induced bronchopulmonary dysplasia (BPD) via the nuclear factor‐κB (NF‐κB) p65 signaling pathway},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2024},
  doi = {10.1002/jbt.23680}
}
Kostenlos starten →